Intravenous Immunoglobulin (IVIG) Market To Make Great Impact In Near Future

According to a recent market study published by Transparency Market Research (TMR), Intravenous immunoglobulin (IVIG)is a blood product administered intravenously. These are mainly used for the treatment of immune deficiencies, autoimmune diseases and acute infections. IVIG is given as a plasma protein replacement therapy for immune deficient patients (i.e. patients have decreased or abolished antibody productions). Intravenous immunoglobulin is administered to maintain sufficient antibody levels of a patient in order to prevent infections or to enhance immunity. There are different intravenous immunoglobulinproducts availableas trade names in the market namely Gamunex, Flebogamma,Gammagard and Privigen.

The global intravenous immunoglobulin market is witnessing high growth due to growing geriatricpopulation, rising health expenditure and increasing number of patients with bleeding disorder. In addition,the market of intravenous immunoglobulinproducts is also witnessing positive growth owing to increasing number of patients suffering from autoimmune diseases, asthma and other pathological conditions coupled with risinguse of IVIG. Technological advancements and introduction of new improved therapies for the treatment of these diseases will further propel the growth of this market. However, side effects such as dermatitis, acute kidney injury and venous thrombosis with the use of IVIG, high cost of treatment and stringent restrains the market growth.

Get Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1930

Geographically, North America dominates the global intravenous immunoglobulin marketdue to increasing patient population suffering from autoimmune diseases, asthma and other diseases.Europe is considered as the second largest market of intravenous immunoglobulin due to increasing aging population. According to Eurostat (European Commission) report published in 2013, around 17.8% of the European population were 65 years and above. In addition, Asia-Pacific countries are the emerging nationsfor the global intravenous immunoglobulinmarket due to increasing healthcare awareness among the patient population.

Some of the major players operating in this marketincludeBaxter International Inc., Bharat Serums and Vaccines Ltd., Biotest AG,CSL Limited, Grifols S.A., Octapharma AG, OMRIX Biopharmaceuticals Ltd, Kedrion S.p.A and others.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

• North America
• Asia Pacific
• Europe
• Rest of the World  

This report provides comprehensive analysis of

• Market growth drivers
• Factors limiting market growth
• Current market trends
• Market structure
• Market projections for upcoming years

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.    

Browse the full Market Research Report: http://www.transparencymarketresearch.com/intravenous-immunoglobulin-market.html

About Us
 
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.
 
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
 
Contact
Mr. Sudip Saha
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/